100+ Free Examen Integrado Farmacia Hospitalaria Practice Questions

Prepare for the Examen Integrado de Residencias de la Salud — Farmacia Hospitalaria (Argentina) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately

100+ Questions

100% Free

Loading practice questions...

Same family resources

Explore More Argentina Health Residencies Integrated Examination (Examen Integrado de Residencias de la Salud — MSAL / CAEI)

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Argentina Biochemistry Residencies Integrated Examination (Examen Integrado de Residencias — Bioquímica)

Practice Questions100 questions

Argentina Kinesiology Residencies Integrated Examination (Examen Integrado de Residencias — Kinesiología)

Practice Questions100 questions

Argentina Medical Residencies Integrated Examination (Examen Integrado de Residencias — Medicina)

Practice Questions100 questions

Argentina Nursing Residencies Integrated Examination (Examen Integrado de Residencias — Enfermería)

Practice Questions100 questions

Argentina Nutrition Residencies Integrated Examination (Examen Integrado de Residencias — Nutrición)

Practice Questions100 questions

Argentina Psychology Residencies Integrated Examination (Examen Integrado de Residencias — Psicología)

Practice Questions100 questions

2026 Statistics

Key Facts: Examen Integrado Farmacia Hospitalaria Exam

100

Multiple-Choice Questions

MSAL / CAEI 2026

4 hours

Exam Duration (240 min)

Resolución 555/2026

Free ($0)

Examination Fee

Ministerio de Salud

5 Domains

Curriculum Areas

AAFH / MSAL Examen Integrado — temario oficial

Digital

Testing Delivery Mode

SISA / MSAL Platform

3 Years

Standard Residency Duration

Sistema Nacional de Residencias

The Argentina Hospital Pharmacy Integrated Residency Exam (Examen Integrado de Farmacia Hospitalaria) consists of 100 multiple-choice questions administered over 3 hours on digital tablets. It is completely free of charge and tests clinical pharmacology, sterile compounding, TDM, pharmacovigilance, and pharmacy laws. Results are combined with undergraduate GPA to determine nationwide hospital residency allocations.

Sample Examen Integrado Farmacia Hospitalaria Practice Questions

Try these sample questions to test your Examen Integrado Farmacia Hospitalaria exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1Under hospital Antimicrobial Stewardship Programs (PROA - Programas de Optimización de Antimicrobianos), which pharmacokinetic/pharmacodynamic (PK/PD) index best predicts the clinical and bacteriological efficacy of beta-lactam antibiotics such as piperacillin/tazobactam and meropenem in critically ill patients?

A.The ratio of maximum peak serum concentration to minimum inhibitory concentration (Cmax/MIC)

B.The percentage of the dosing interval during which the free (unbound) drug concentration exceeds the MIC (%fT > MIC)

C.The ratio of the 24-hour area under the concentration-time curve to the MIC (AUC24/MIC)

D.The post-antibiotic effect (PAE) duration exceeding the dosing interval

Explanation: Beta-lactams exhibit time-dependent bactericidal activity, meaning their clinical and microbiological eradication correlates directly with the percentage of time during the dosing interval that the free (unbound) drug concentration remains above the pathogen's minimum inhibitory concentration (%fT > MIC). In critically ill septic patients, maximizing %fT > MIC (aiming for 70–100% fT > 1–4x MIC) through prolonged or continuous intravenous infusions significantly improves clinical outcomes.

2A clinical pharmacist reviews an empiric antibiotic prescription for an intensive care patient with suspected hospital-acquired pneumonia caused by non-fermenting Gram-negative bacilli. Which carbapenem lacks clinical activity against Pseudomonas aeruginosa and Acinetobacter baumannii?

A.Meropenem

B.Imipenem/Cilastatin

C.Ertapenem

D.Doripenem

Explanation: Ertapenem differs structurally from group 2 carbapenems (meropenem, imipenem, doripenem) because it possesses a bulky, highly charged benzoate substituent at the C-2 position that prevents adequate penetration through the outer membrane porin channels (OprD) of non-fermenting Gram-negative bacilli such as Pseudomonas aeruginosa and Acinetobacter baumannii, as well as Enterococcus faecalis. Consequently, ertapenem is not indicated for nosocomial infections where non-fermenters are suspected.

3A hospitalized patient has a documented history of severe Type I (IgE-mediated) anaphylactic reaction to penicillin. Which beta-lactam agent can safely be administered without cross-reactivity, except in cases where the patient has a specific allergy to ceftazidime?

A.Cefepime

B.Aztreonam

C.Ampicillin/Sulbactam

D.Piperacillin/Tazobactam

Explanation: Aztreonam is a monobactam possessing a monocyclic beta-lactam core that does not share cross-reactivity with bicyclic penicillins, cephalosporins, or carbapenems, making it safe for patients with severe IgE-mediated beta-lactam allergies. The only notable clinical exception is ceftazidime, because aztreonam and ceftazidime share an identical R1 acyl side chain (an aminothiazole ring with a 2-carboxyprop-2-yl-oxyimino group), which can trigger immunologic cross-reactions.

4Which pharmacokinetic rationale supports extended-interval (once-daily) dosing of aminoglycosides (such as amikacin or gentamicin) over conventional multiple-daily dosing regimens in hospital practice?

A.Aminoglycosides exhibit time-dependent bactericidal activity requiring constant low serum concentrations

B.Maximizing the Cmax/MIC ratio (>= 8–10) enhances concentration-dependent bacterial killing while the prolonged drug-free interval exploits the post-antibiotic effect (PAE) and minimizes renal cortical accumulation

C.Once-daily dosing increases tubular secretion by renal P-glycoprotein, completely preventing ototoxicity

D.Aminoglycosides undergo saturable hepatic first-pass metabolism that is bypassed by single daily intravenous boluses

Explanation: Aminoglycosides exhibit concentration-dependent bactericidal killing driven by the peak-to-MIC ratio (Cmax/MIC >= 8–10) and a substantial post-antibiotic effect (PAE) lasting several hours against Gram-negative bacilli. Renal cortical uptake into proximal tubular cells via megalin receptors is saturable; high single daily peaks do not proportionally increase tissue uptake, and the subsequent prolonged low trough concentrations (<1 mcg/mL for gentamicin, <4-5 mcg/mL for amikacin) allow cellular clearance, significantly reducing nephrotoxicity.

5During the intravenous administration of vancomycin 1,000 mg over 20 minutes, a patient develops intense erythema, pruritus, and flushing of the upper chest, neck, and face, without airway compromise or angioedema. What is the pharmacological mechanism and primary corrective measure for this reaction?

A.IgE-mediated Type I anaphylaxis; immediately administer intramuscular epinephrine and permanently discontinue glycopeptides

B.Non-immune direct mast cell and basophil degranulation triggered by rapid infusion; slow the infusion rate to <= 10 mg/min (infusion over at least 60–120 minutes) and administer antihistamines

C.Type III immune complex vasculitis; initiate high-dose intravenous methylprednisolone

D.Direct alpha-1 adrenergic stimulation causing facial vasodilation; administer intravenous phentolamine

Explanation: This reaction represents Vancomycin Infusion Reaction (formerly called 'Red Man Syndrome'), which is a non-immunologic, rate-dependent reaction caused by direct activation of mast cells and basophils (via MRGPRX2 receptors) causing histamine release. It is prevented or managed by slowing the infusion rate to no faster than 10 mg/minute (at least 60 minutes per 1,000 mg or 120 minutes for doses >= 1,500 mg) and premedicating with H1/H2 antihistamines if necessary.

6A hospitalized patient receiving oral linezolid 600 mg every 12 hours for an enterococcal osteomyelitis is concurrently prescribed sertraline 100 mg daily for depression. Which severe adverse pharmacodynamic interaction must the hospital pharmacist monitor for and prevent?

A.Severe prolonged QT interval prolongation leading to Torsades de Pointes

B.Serotonin syndrome (central serotonergic hyperactivation) due to non-selective, reversible monoamine oxidase (MAO) inhibition by linezolid

C.Acute hypertensive encephalopathy secondary to induction of peripheral catechol-O-methyltransferase (COMT)

D.Severe neuromuscular blockade resulting in flaccid paralysis

Explanation: Linezolid is a synthetic oxazolidinone antibacterial that functions as a weak, reversible, non-selective inhibitor of monoamine oxidase A and B (MAOI). When combined with selective serotonin reuptake inhibitors (SSRIs) such as sertraline, it prevents the degradation of intrasynaptic serotonin, precipitating potentially life-threatening serotonin syndrome (hyperreflexia, clonus, autonomic instability, hyperthermia, and agitation).

7Which safety warning issued by ANMAT and international regulatory authorities highlights a major musculoskeletal and cardiovascular toxicity associated with systemic fluoroquinolones (e.g., ciprofloxacin, levofloxacin)?

A.Idiopathic pulmonary fibrosis and subacute thyroiditis

B.Tendinopathy / Achilles tendon rupture and increased risk of aortic aneurysm / dissection

C.Aplastic anemia and idiosyncratic hepatic veno-occlusive disease

D.Malignant hyperthermia and rhabdomyolysis triggered by succinylcholine

Explanation: ANMAT and other international health agencies (FDA, EMA) have issued boxed warnings regarding systemic fluoroquinolones due to severe, potentially irreversible toxicities, including tendinitis and tendon rupture (most commonly affecting the Achilles tendon via matrix metalloproteinase upregulation and collagen degradation), peripheral neuropathy, QTc prolongation, and structural degradation of the vascular extracellular matrix leading to aortic aneurysm and dissection.

8A clinical pharmacist in an infectious diseases ward reviews the pharmacokinetics of macrolide antibiotics. Which macrolide is the most potent inhibitor of hepatic Cytochrome P450 3A4 (CYP3A4), requiring strict dosage adjustments or avoidance of CYP3A4 substrates such as simvastatin, carbamazepine, and cyclosporine?

A.Azithromycin

B.Clarithromycin

C.Spiramycin

D.Roxithromycin

Explanation: Clarithromycin (along with erythromycin) forms an inactive nitrosoalkane metabolic intermediate complex with the heme iron of Cytochrome P450 3A4, causing quasi-irreversible mechanism-based inhibition of CYP3A4. In contrast, azithromycin has a 15-membered azalide ring structure that does not form these nitrosoalkane complexes and therefore does not meaningfully inhibit CYP3A4.

9In the management of multi-drug resistant (MDR) Acinetobacter baumannii infections with intravenous colistin, what is the exact active pharmacological agent administered as an inactive prodrug, and what is its primary dose-limiting toxicity?

A.Administered as active polymyxin B; dose-limiting toxicity is severe hemolytic anemia

B.Administered as inactive colistimethate sodium (CMS), which hydrolyzes in vivo to active colistin (polymyxin E); primary dose-limiting toxicity is acute tubular necrosis (nephrotoxicity)

C.Administered as colistin base activity, which is metabolically oxidized into polymyxin M; primary toxicity is irreversible ototoxicity

D.Administered as colistin sulfate; primary toxicity is acute hepatic cholestasis

Explanation: Parenteral colistin is supplied as the polyanionic prodrug colistimethate sodium (CMS / colistimetato de sodio), which undergoes non-enzymatic spontaneous hydrolysis in vivo to form active colistin (polymyxin E). Colistin's primary dose-limiting adverse effect is acute nephrotoxicity caused by direct damage to renal proximal tubular epithelial cells (cell membrane lysis and mitochondrial injury), followed by concentration-dependent neurotoxicity.

10A patient with systemic cryptococcal meningitis is treated with conventional amphotericin B deoxycholate. To mitigate amphotericin B-induced renal tubular vasoconstriction and distal tubular necrosis, which evidence-based protocol should the hospital pharmacist recommend prior to each daily infusion?

A.Intravenous pre-hydration with 500–1,000 mL of 0.9% sodium chloride (normal saline) and proactive potassium/magnesium supplementation

B.Intravenous pre-infusion of 50% hypertonic dextrose with regular insulin

C.Premedication with high-dose oral sodium bicarbonate to induce systemic metabolic alkalosis

D.Administration of high-dose loop diuretics (furosemide 80 mg IV) 30 minutes before infusion

Explanation: Conventional amphotericin B deoxycholate induces afferent arteriolar vasoconstriction (decreasing GFR) and damages the distal renal tubular membranes, causing renal tubular acidosis and severe urinary wasting of potassium and magnesium. Intravenous pre-loading with sodium chloride 0.9% (500–1,000 mL) enhances sodium delivery to the macula densa, suppressing tubuloglomerular feedback vasoconstriction and significantly blunting nephrotoxicity.

About the Examen Integrado Farmacia Hospitalaria Exam

The Examen Integrado de Residencias de la Salud para Farmacia Hospitalaria is the official competitive entrance examination in Argentina for licensed pharmacists seeking entry into hospital pharmacy residency training programs (Residencias de Farmacia Hospitalaria y Farmacia Clínica). Governed by the Ministerio de Salud de la Nación in technical coordination with the Asociación Argentina de Farmacéuticos de Hospital (AAFH) and the Comité Asesor del Examen Integrado (CAEI) under Resolución Ministerial 555/2026, the examination assesses clinical therapeutics, antimicrobial stewardship (PROA), sterile compounding, parenteral nutrition, clinical pharmacokinetics and therapeutic drug monitoring (TDM), pharmacovigilance, patient safety, hospital inventory management (ABC/VEN), and national pharmacy legislation (Leyes 17.565, 17.818, 19.303, and ANMAT dispositions). Delivered in a synchronized digital format across national testing centers, passing this examination allows candidates to secure full-time, salaried postgraduate residency positions in top public and university hospitals across the country. Language note: the Examen Integrado is set and sat entirely in Spanish, against the official MSAL temario for Farmacia Hospitalaria. These practice questions are an English-language multiple-choice study adaptation built from that official scope — they are not an official translation, not published or endorsed by the Ministerio de Salud de la Nación, and not a simulation of the exam's Spanish-language testing environment. Official exam names, Argentine statute numbers and local clinical terms are kept in Spanish so you can match them to the real bibliography.

Assessment

100 multiple-choice questions administered in a single 3-hour session on standardized digital tablets/computers at accredited examination centers across Argentina under Resolución Ministerial 555/2026.

Time Limit

3 hours (180 minutes)

Passing Score

Ranked by competitive merit order (orden de mérito): 1 point per correct answer out of 100, with no penalty for wrong or blank answers; the exam score is combined with the candidate's certified undergraduate grade point average. Resolución 555/2026 sets no national minimum score — each participating concurso publishes its own cut-off and vacancy list.

Exam Fee

Free ($0 ARS) for all public national, provincial, and municipal residency programs. (Ministerio de Salud de la Nación (Dirección Nacional de Calidad y Desarrollo del Talento en Salud) / CAEI / AAFH)

Examen Integrado Farmacia Hospitalaria Exam Content Outline

30%

Clinical Pharmacology & Therapeutics

Antimicrobial stewardship (PROA), PK/PD indices of antibacterials (beta-lactams, aminoglycosides, glycopeptides, fluoroquinolones, carbapenems, colistin, linezolid), antifungal and antiviral pharmacotherapy, cardiovascular pharmacology (ACEI/ARBs, beta-blockers, CCBs, DOACs, heparins, warfarin), analgesia and palliative care, central nervous system agents, and oncology supportive care.

25%

Hospital Pharmacy Practice & Sterile Compounding

Pharmacy and Therapeutics Committee (CFT) structure and formulary selection, Unit Dose Drug Distribution System (SDMDU), cleanroom classification (ISO 14644-1 Classes 5, 7, 8), laminar airflow workbenches (vertical vs horizontal), aseptic technique validation (media fill), Total Parenteral Nutrition (NPT: osmolarity, calcium-phosphate precipitation), hazardous drug/cytotoxic compounding, and cold chain management.

15%

Pharmacovigilance, Patient Safety & Drug Interactions

ANMAT National Pharmacovigilance Program, Rawlins-Thompson ADR classification, Naranjo causality assessment algorithm, ISMP/AAFH High-Alert Medications (concentrated electrolytes, insulin, anticoagulants, opioids), Look-Alike Sound-Alike (LASA) safety barriers, medication reconciliation, and severe drug-drug/drug-nutrient interactions.

15%

Clinical Pharmacokinetics & Therapeutic Drug Monitoring (TDM)

Fundamental PK equations (Vd, clearance, half-life, elimination rate constant, steady-state, loading/maintenance dosing), non-linear Michaelis-Menten kinetics, therapeutic drug monitoring and target ranges (vancomycin AUC24/MIC, aminoglycosides, digoxin, phenytoin with Sheiner-Tozer correction, lithium, tacrolimus/cyclosporine), and Cockcroft-Gault renal dosage adjustments.

15%

Pharmacy Legislation, Bioethics & Hospital Formulary Management

Ley 17.565 (Reglamentación del Ejercicio de la Farmacia), Ley 17.818 (Estupefacientes), Ley 19.303 (Psicotrópicos), Ley 26.657 (Salud Mental), Farmacopea Argentina VII Edición, ANMAT National Traceability System (Disposición 3683/2011), ABC and VEN inventory matrices, Economic Order Quantity, FEFO inventory rotation, and Good Clinical Practice (GCP) research ethics.

How to Pass the Examen Integrado Farmacia Hospitalaria Exam

What You Need to Know

Passing score: Ranked by competitive merit order (orden de mérito): 1 point per correct answer out of 100, with no penalty for wrong or blank answers; the exam score is combined with the candidate's certified undergraduate grade point average. Resolución 555/2026 sets no national minimum score — each participating concurso publishes its own cut-off and vacancy list.
Assessment: 100 multiple-choice questions administered in a single 3-hour session on standardized digital tablets/computers at accredited examination centers across Argentina under Resolución Ministerial 555/2026.
Time limit: 3 hours (180 minutes)
Exam fee: Free ($0 ARS) for all public national, provincial, and municipal residency programs.

Keys to Passing

Work through all 100 available questions
Review every answer and explanation
Track weak areas and revisit them
Use our AI tutor for tough concepts

Examen Integrado Farmacia Hospitalaria Study Tips from Top Performers

1Prioritize antimicrobial stewardship (PROA) and PK/PD principles: know which antibiotics are time-dependent (%T>MIC, e.g. beta-lactams), concentration-dependent (Cmax/MIC, e.g. aminoglycosides), or exposure-dependent (AUC24/MIC, e.g. vancomycin, fluoroquinolones).

2Master Total Parenteral Nutrition (NPT) compounding rules: always add phosphate first and calcium last, maintain amino acid concentration >=2.5% to protect emulsion, and avoid high pH that triggers dibasic calcium phosphate precipitation.

3Memorize cleanroom classifications (ISO 14644-1): ISO Class 5 for laminar flow workbenches, ISO Class 7 for cleanroom buffer areas, and ISO Class 8 for ante-rooms; use negative pressure with total exhaust (BSC Class II Type B2) for cytotoxic compounding.

4Understand therapeutic drug monitoring (TDM) equations: practice Cockcroft-Gault CrCl calculations, Sheiner-Tozer adjusted phenytoin for hypoalbuminemia, and current vancomycin AUC24/MIC target monitoring (400–600 mg·h/L).

5Review high-alert medications and patient safety algorithms: study the Naranjo algorithm scoring, ISMP concentrated electrolyte safety guidelines (never store concentrated KCl on general wards), and Look-Alike Sound-Alike (LASA) Tall Man Lettering.

6Learn the legal distinctions among controlled drug schedules: Ley 17.818 (Estupefacientes: Listas I, II, III with triplicate official vouchers/Recetario Oficial) versus Ley 19.303 (Psicotrópicos: Lista I prohibited, Lista II official vouchers, Listas III and IV standard prescription archives).

Frequently Asked Questions

What is the Examen Integrado de Residencias de Farmacia Hospitalaria in Argentina?

It is the unified, national competitive entrance examination administered by the Ministerio de Salud de la Nación in collaboration with provincial health ministries, the CAEI, and the Asociación Argentina de Farmacéuticos de Hospital (AAFH). It allows graduates holding a university pharmacy degree (Farmacéutico or Licenciado en Farmacia) to compete for salaried postgraduate hospital pharmacy residency positions (Residencias de Farmacia Hospitalaria) across public and university hospitals in Argentina.

How is the examination structured and administered?

The examination consists of 100 multiple-choice questions, each with 4 answer choices and a single correct answer. It is administered in a single 4-hour (180 minutes) session using digital tablets or computer terminals under standardized national protocols established by Resolución Ministerial 555/2026.

How is the final merit ranking (Orden de Mérito) calculated?

The final score is computed through a standardized formula that combines the examination score (evaluated on a scale up to 100 points, 1 point per question, with no negative marking) with the candidate's undergraduate university grade point average (promedio general de la carrera con aplazos). In some provincial sub-competitions, background credentials (antecedentes curriculares) may contribute a small additional percentage.

What are the eligibility requirements to sit for the pharmacy residency exam?

Applicants must hold a recognized university degree in Pharmacy (Farmacéutico or Licenciado en Farmacia) issued by an accredited Argentine national or private university, or a validated/convalidated foreign degree. Applicants must also register through the Sistema Integrado de Información Sanitaria Argentino (SISA) within the annual inscription window and satisfy graduation year limits (typically within 5 years of graduation for first-year entry residency posts).

What are the primary clinical and hospital pharmacy topics covered on the exam?

The blueprint covers five core domains: Clinical Pharmacology & Antimicrobial Stewardship (~30%), Hospital Pharmacy Operations & Sterile Compounding (~25%), Pharmacovigilance & Patient Safety (~15%), Clinical Pharmacokinetics & TDM (~15%), and Pharmacy Legislation & Inventory Management (~15%).

Is there any registration or examination fee?

No. The Examen Integrado de Residencias de la Salud is completely free of charge ($0 ARS) for all applicants, as it is fully funded and coordinated by the Argentine public health system.

What key national legislation and standards must candidates master?

Candidates must thoroughly know Ley Nacional 17.565 (Ejercicio Profesional Farmacéutico), Ley 17.818 (Estupefacientes), Ley 19.303 (Psicotrópicos), Ley 26.657 (Salud Mental), Farmacopea Argentina VII Edición monographs, ANMAT traceability regulations (Disposición 3683/2011), and AAFH Good Hospital Pharmacy Compounding Practices.

Is this practice bank in Spanish like the real exam?

No. The Examen Integrado is administered in Spanish only. This bank is an English-language multiple-choice study adaptation derived from the official MSAL temario and bibliography, intended for candidates who prefer to revise the underlying clinical knowledge in English. It is not an official translation and does not reproduce official exam items; Argentine law numbers, programme names and clinical terminology are retained in Spanish so they map onto the real exam.